The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 5
- −1 vs. Q3 2024
- Portfolio value
- $55.7M
- −$13.8M (−19.9%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ORICOric Pharmaceuticals, Inc. | COM | 3,540,777 | $28.6M | 51.3% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $13.4M | 24.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 810,088 | $11.6M | 20.9% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,328,613 | $2.10M | 3.8% | −1,352,008−50.4% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 46 | $2.09K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2024 (1)
Positions held at the end of Q3 2024 that are gone from this filing.